A detailed history of Cullinan Associates Inc transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Cullinan Associates Inc holds 30,000 shares of WST stock, worth $9.43 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
30,000
Previous 30,000 -0.0%
Holding current value
$9.43 Million
Previous $9.88 Million 8.88%
% of portfolio
0.5%
Previous 0.57%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$338.27 - $413.0 $1.35 Million - $1.65 Million
-4,000 Reduced 11.76%
30,000 $11.9 Million
Q1 2023

Apr 05, 2023

SELL
$232.5 - $346.47 $195,067 - $290,688
-839 Reduced 2.41%
34,000 $11.8 Million
Q4 2022

Jan 11, 2023

BUY
$209.34 - $261.61 $4.36 Million - $5.45 Million
20,839 Added 148.85%
34,839 $8.2 Million
Q1 2022

Apr 21, 2022

BUY
$357.49 - $445.92 $5 Million - $6.24 Million
14,000 New
14,000 $5.75 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.3B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.